Encoded Therapeutics, Inc.: Encoded Therapeutics Inc.: New Preclinical Data from Encoded Therapeutics Demonstrate Therapeutic Potential of its One-time, Non-opioid Gene Therapy Candidate for Chronic Pain

Press Release: Encoded Therapeutics, Inc. : Encoded Therapeutics Reports Clinical Progress of ETX101 Gene Therapy for Dravet Syndrome, Recaps 2024 Corporate Achievements and Provides 2025 Outlook

Encoded Therapeutics, Inc.: Encoded Cuts 29% of Workforce to Extend Cash Runway, Advance Pipeline

Press Release: Encoded Therapeutics, Inc. : Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit

Press Release: Encoded Therapeutics, Inc. : Encoded Therapeutics Presents Preclinical Data Across its Gene Therapy Portfolio at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Press Release: Encoded Therapeutics, Inc. : Encoded Therapeutics Provides Pipeline Updates From Its Vector Engineering Platform Ahead of Four Preclinical Presentations at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Encoded Therapeutics, Inc.: Encoded Therapeutics Announces UK CTA Approval for Dravet Syndrome Gene Therapy Candidate ETX101